Safety and efficacy at 1 year in children and adolescents with chronic hepatitis b (chb) receiving tenofovir alafenamide (taf)

HEPATOLOGY(2023)

引用 0|浏览28
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要